DIONYS FUSTER: Open Payments
NPI 1144665829 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 11 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $125 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $136 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| Tris Pharma Inc | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
Products named: INVEGA SUSTENNA, FANAPT, CAPLYTA, TRINTELLIX, VRAYLAR, Onyda XR, Dyanavel XR.
Industry payments across FL — which companies pay providers there.
